Bacterial vectors for imaging and cancer gene therapy: a review

Area of Science:

• Oncology
• Biotechnology
• Medical Imaging

Background:

• Conventional anticancer treatments face challenges due to drug resistance in advanced cancers.
• There is a critical need for selective tumor-targeting therapies with minimal toxicity to normal tissues.
• Engineered bacteria present a novel therapeutic strategy to overcome limitations of traditional cancer treatments.

Purpose of the Study:

• To review current imaging technologies for monitoring engineered bacterial vectors in vivo.
• To discuss the progress in developing bacterial-specific real-time imaging modalities.
• To highlight the importance of imaging for the clinical development of bacterial gene delivery in oncology.

Main Methods:

• Review of pre-clinical and clinical investigations of bacterial vectors for cancer gene delivery.
• Analysis of available imaging technologies for tracking bacterial trafficking and levels.
• Discussion of advancements in real-time imaging for bacterial monitoring.

Main Results:

• Bacteria naturally home to tumors, replicating locally either externally or within tumor cells.
• Effective monitoring of bacterial vector trafficking and levels over time is essential.
• Development of bacterial-specific real-time imaging is key for successful clinical translation.

Conclusions:

• Engineered bacteria show potential as selective anticancer agents.
• Real-time in vivo imaging is critical for advancing bacterial gene delivery therapies.
• Further development of imaging modalities will facilitate the clinical application of bacterial-based cancer treatments.